Title: Synthesis and characterizations of novel quinoline derivatives having mixed ligand activities at the kappa and mu receptors: Potential therapeutic efficacy against morphine dependence.
Journal: Bioorganic & medicinal chemistry 20090815
100129-45-1
100638-26-4
115022-95-2
183111-59-3
620-71-3
99585-98-5
356086-86-7 | 4-(p-Tolylamino)butan-1-ol | AA00BZX4 | MFCD02603506
3302-06-5 | 3,4-Dimethylpentanoic acid | AA00C030 | MFCD02258589
41598-07-6 | PROSTAGLANDIN D2 | AA00C09T | MFCD00077857
4038-92-0 | 1-(2-Diethylaminoethyl)piperazine | AA00C0GE | MFCD00167968
404366-59-2 | 5-Bromo-6-chloro-3-indoxyl phosphate, disodium salt monohydrate | AA00C0M6 | MFCD05662349
35700-22-2 | 15(R)-15-METHYL PROSTAGLANDIN F2ALPHA METHYL ESTER | AA00C0SU | MFCD01632740
3798-89-8 | 1-Fluoro-3-phenoxybenzene | AA00C0W9 | MFCD17015805
24520-59-0 | 1-(Bicyclo[2.2.1]heptan-2-yl)ethanamine hydrochloride | AA00C127 | MFCD02973820
220527-24-2 | (CHLORODIMETHYLSILYL)-6-[2-(CHLORODIMETHYLSILYL)ETHYL]BICYCLOHEPTANE | AA00C1AO | MFCD08275505
215868-23-8 | 6,8-DIFLUORO-7-HYDROXY-4-METHYLCOUMARIN | AA00C1LZ | MFCD01073675